High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China.

In this study, the prevalence of the plasmid-mediated quinolone resistance (PMQR) genes among pediatric clinical isolates of Escherichia coli and Klebsiella pneumoniae was investigated. A total of 243 nonduplicate clinical isolates of E. coli and K. pneumoniae collected between January 2010 and December 2012 from Beijing, China, were studied. In total, 55 isolates (22.63%) were positive for PMQR genes, the most frequently detected gene was qnrS (13.2%), followed by aac(6')-Ib-cr (6.2%) and qnrB (3.7%). The qnrA and qepA genes were not detected. Furthermore, 92.73% (51/55) produced extended-spectrum β-lactamases (ESBLs) and 21.82% (12/55) were resistant to quinolones. DNA sequencing results showed that 14.55% (8/55) of isolates possessed gyrA mutations, while 1.82% (1/55) had parC mutations in the quinolone resistance-determining region (QRDR). Nalidixic acid or ciprofloxacin resistance of the transconjugants increased from 2- to 32-fold. Enterobacterial repetitive intergenic consensus sequence polymerase chain reaction typing indicated that most isolates were not clonally related. Our findings showed that the PMQR detection rate among pediatric clinical isolates of E. coli and K. pneumoniae was high in China. PMQR-positive strains were more common among ESBL-producing and ciprofloxacin-susceptible isolates. Conjugation experiments showed that these isolates could be transferred horizontally. The present study highlights the high prevalence of PMQR in Chinese pediatrics who are not treated with quinolones.

[1]  M. Bulanda,et al.  The High Prevalence of Plasmid-Mediated Quinolone Resistance Among Very Low Birth-Weight Infants in Poland. , 2015, Microbial drug resistance.

[2]  H. Barrios,et al.  Development of a Multiplex-PCR probe system for the proper identification of Klebsiella variicola , 2015, BMC Microbiology.

[3]  Yonghong Xiao,et al.  Molecular Epidemiology and Genetic Diversity of Fluoroquinolone-Resistant Escherichia coli Isolates from Patients with Community-Onset Infections in 30 Chinese County Hospitals , 2014, Journal of Clinical Microbiology.

[4]  S. Nakagawa,et al.  Characterization of plasmid-mediated quinolone resistance determinants in Klebsiella pneumoniae and Escherichia coli from Tokai, Japan. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  D. Hooper,et al.  Clinical Importance and Epidemiology of Quinolone Resistance , 2014, Infection & chemotherapy.

[6]  N. Osheroff,et al.  Mechanism of Quinolone Action and Resistance , 2014, Biochemistry.

[7]  E. Cambau,et al.  Trend of plasmid-mediated quinolone resistance genes at the Children's Hospital in Tunisia. , 2014, Journal of medical microbiology.

[8]  G. Jacoby,et al.  Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. , 2013, The Journal of antimicrobial chemotherapy.

[9]  H. Barrios,et al.  Characterization of Plasmid-Mediated Quinolone Resistance (PMQR) Genes in Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Pediatric Clinical Isolates in Mexico , 2013, PloS one.

[10]  N. Kim,et al.  Prevalence of plasmid-mediated quinolone resistance genes and ciprofloxacin resistance in pediatric bloodstream isolates of Enterobacteriaceae over a 9-year period. , 2013, Japanese journal of infectious diseases.

[11]  Weiwei Wang,et al.  Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants. , 2011, Microbial drug resistance.

[12]  J. Ayala,et al.  Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. , 2011, The Journal of antimicrobial chemotherapy.

[13]  N. Caroff,et al.  Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. , 2011, Pathologie-biologie.

[14]  Jinwei Huang,et al.  High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China. , 2011, International journal of antimicrobial agents.

[15]  P. McDermott,et al.  Plasmid-mediated Quinolone Resistance among Non-TyphiSalmonella enterica Isolates, USA , 2010, Emerging infectious diseases.

[16]  X. Ye,et al.  Decreased quinolone susceptibility in high percentage of Enterobacter cloacae clinical isolates caused only by Qnr determinants. , 2010, Diagnostic microbiology and infectious disease.

[17]  Yonghong Yang,et al.  The prevalence of plasmid‐mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC‐producing Escherichia coli from Chinese pediatric patients , 2009, Microbiology and immunology.

[18]  A. Robicsek,et al.  Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat , 2009, Clinical Microbiology Reviews.

[19]  G. Jacoby,et al.  Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period , 2008, Antimicrobial Agents and Chemotherapy.

[20]  Li Wang,et al.  Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China , 2008, BMC infectious diseases.

[21]  K. Kimura,et al.  New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical Isolate , 2007, Antimicrobial Agents and Chemotherapy.

[22]  A. Sundsfjord,et al.  Effects of Phenotype and Genotype on Methods for Detection of Extended-Spectrum-β-Lactamase-Producing Clinical Isolates of Escherichia coli and Klebsiella pneumoniae in Norway , 2006, Journal of Clinical Microbiology.

[23]  N. Woodford,et al.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. , 2006, The Journal of antimicrobial chemotherapy.

[24]  A. Robicsek,et al.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase , 2006, Nature Medicine.

[25]  G. Jacoby,et al.  Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China , 2003, Antimicrobial Agents and Chemotherapy.

[26]  G. Jacoby,et al.  Quinolone resistance from a transferable plasmid , 1998, The Lancet.